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Blood lossAbstract Objective: The aim of this study was to evaluate the effect of intravenous infusion of
dexmedetomidine on intraoperative hemodynamics and blood loss during open nephrolithotomy
under general anesthesia in adult patients.
Method: 50 male and female patients, ASA physical status I and II aged 20–60 years old scheduled
for open nephrolithotomy under general anesthesia were randomly allocated into two equal groups:
Group D (n= 25): received a bolus dose of IV dexmedetomidine.
1 lg/kg over 10 min before induction of anesthesia and then IV infusion of 0.1–0.5 lg/kg/h guided
by the hemodynamics.
Group P (n= 25): received a bolus dose of 10 ml Ringer lactate solution before induction of
anesthesia, and infusion was continued during surgery.
General anesthesia was induced in all patients using fentanyl, propofol and atracurium. The follow-
ing parameters were recorded: heart rate and systolic and diastolic arterial blood pressure: before
and after induction of anesthesia and then every 15 min intraoperatively, volume of blood loss
(ml), laboratory hemoglobin % and hematocrit concentration: preoperative, intraoperative and
immediate postoperative and number of the transfused units of PRBCs.
Results: Intraoperative heart rate and systolic and diastolic arterial blood pressure were
statistically signiﬁcantly lower in group D than in group P. The intraoperative blood volume lost
was statistically signiﬁcantly higher in group P than in group D. A number of the transfused units
of PRBCs, intraoperative and postoperative hemoglobin % and hematocrit concentration were
statistically signiﬁcantly lower in group P than in group D.Mobile:
322 D.A. Rashwan et al.Conclusion: Dexmedetomidine infusion in patients undergoing open nephrolithotomy under
general anesthesia was associated with intraoperative hemodynamic stability, which decreases
intraoperative blood loss and the need for intraoperative blood transfusion.
ª 2015 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.1. Introduction
Dexmedetomidine is an selective a-2 agonist with sedative,
analgesic, sympatholytic cardiovascular effects, and it pro-
vided hemodynamic stability without causing respiratory
depression [1,2].
Previous studies showed that dexmedetomidine decreases
skin bleeding in animals, as it causes peripheral vasoconstric-
tion, which resulted in minimal bleeding with skin incision
and intraoperatively [3].
Renal stones is a common disease [4], and open surgery
for renal stones is associated with blood loss which may be
in large amount due to the high vascularity of the kidneys
as it received 20% of the cardiac output or due to prolonged
surgical time if the stone is large, thus increasing the blood
loss [5] and the need for blood transfusion. A study by
Khalaf et al. [6] showed that primary or secondary hemor-
rhage occurred in 186 patients (35%).
The decision to intraoperative blood transfusion must bal-
ance the known risks of blood transfusion with the need to
provide adequate tissue oxygenation [7].
We hypothesized that intravenous infusion of dexmedeto-
midine in adult patients undergoing open nephrolithotomy
under general anesthesia may provide better intraoperative
hemodynamics, reducing bleeding and the need for blood
transfusion.
The aim of this prospective randomized double-blinded
controlled study was to evaluate the effect of intravenous
dexmedetomidine infusion on intraoperative hemodynamics
and blood loss in adult patients undergoing open nephrolitho-
tomy under general anesthesia.2. Patients and methods
After the approval of the ethical committee of Faculty of
Medicine, Beni Suef University (FMBUS REC, Egypt),
the study was registered at www.AZNCTR clinical trial reg-
istry, with registration number ACTRN12614000389606,
and written informed consents were obtained from 50
patients’ ASA physical status I and II, males and females
aged 20–60 years old, scheduled for elective open
nephrolithotomy under general anesthesia from April 2014
to November 2014.
Patients were excluded if they were ASA more than II, had
a known cardiac arrhythmias, signiﬁcant coagulopathy deﬁned
as (INR> 1.5), use of antiplatelet or anticoagulants, anemic
patients with Hb% less than 10 g/dl.
In the operating room, two wide bore peripheral intra-
venous cannulae were inserted, and monitors were connected
including electrocardiogram, pulse oximetry, noninvasive arte-
rial blood pressure cuff at 5 min intervals and BIS monitor
strip (BIS Sensor; Aspect Medical Systems, USA, Toll free
1-888-BIS Index).The study drugs were prepared by a senior anesthesia resi-
dent unaware of the study protocol.
When patients arrived to the operating theater, they were
randomly assigned to one of two equally divided groups using
a closed envelop technique (n= 25 each):
Group D: received in a separate cannula a bolus dose of
dexmedetomidine (Precedex, dexmedetomidine HCl injection,
200 lg/2 ml), 1 lg/kg over 10 min before induction of anesthe-
sia and then IV infusion of 0.1–0.5 lg/kg/h guided by the
hemodynamics.
Group P: received a bolus dose of 10 ml Ringer lactate
solution before induction of anesthesia and then continuous
infusion till the end of the operation.
General anesthesia was induced, after preoxygenation for
3–5 min with 100% oxygen by face mask, using IV fentanyl
2 lg/kg, propofol 2 mg/kg, atracurium (0.5 mg/kg) and venti-
lated manually with sevoﬂurane 2%, oxygen 100% via a face
mask, intubation with oral cuffed endotracheal tube when the
BIS value reached (40–60) which indicate optimal hypnotic state
[8], anesthesia was maintained with oxygen 100%, sevoﬂurane
(according to the depth of anesthesia guided by BIS to be
between 40% and 60%), muscle relaxation was maintained by
additional doses of atracurium, guided by peripheral nerve stim-
ulator (Life-Tech EZ stim II), mechanical ventilation with main-
tenance of end tidal carbon dioxide 36–40 mmHg. Hypotension
is deﬁned as systolic blood pressure less than 90 mmHgand itwas
treated by decreasing the dexmedetomidine infusion rate and/or
sevoﬂurane concentration and ephedrine in 3 mg IV increments
if needed, and bradycardia is deﬁned as heart rate less than 60
beats perminute andwasmanaged by decreasing the dexmedeto-
midine dose in D group or atropine 0.5 mg IV if needed.
At the end of surgery, 0.25% bupivacaine was injected by
the surgeon at the surgical wound, neuromuscular blockade
was reversed with IV neostigmine 0.04 mg/kg and atropine
0.02 mg/kg, the trachea was extubated when the patient
responds to commands, and all patients were transferred to
PACU, where they received oxygen via face mask for 3–
4 L/min and were monitored.
The following parameters were evaluated and recorded by
senior anesthesia resident unaware of the study protocol:
1. Patient’s characteristics: age, sex, height, weight, ASA
physical status and duration of surgery.
2. Heart rate and systolic and diastolic arterial blood pressure
(primary outcomes): before and after induction of anesthe-
sia and then every 15 min intraoperatively.
Secondary outcomes:
3. Volume of blood loss (ml): in the surgical swabs and suc-
tion bottle.
4. Hemoglobin % and hematocrit concentration: preoperative,
intraoperative and immediate postoperative.
5. Number of the transfused units of PRBCs.
Table 3 Intraoperative systolic arterial blood pressure
(mmHg). Data are presented as mean ± SD.
Time Group D (n= 25) Group P (n= 25)
Preinduction 132.36 ± 12.93 131.44 ± 11.31
After induction 118.4 ± 11.36 121.28 ± 10.33
15 min 116.68 ± 9.70 120.84 ± 11.20
30 min 122.2 ± 7.70 117.64 ± 8.62
45 min 113.6 ± 10.20 118.04 ± 7.99
60 min 114.76 ± 8.88 119.92 ± 6.30*
75 min 116.08 ± 8.14 117.44 ± 8.42
90 min 115.68 ± 7.82 117.8 ± 8.31
105 min 115.72 ± 7.61 121.32 ± 7.79*
120 min 116.92 ± 8.11 121.64 ± 8.34*
135 min 117 ± 8.39 123.44 ± 8.43*
Group D: dexmedetomidine group.
Group P: placebo group.
* P values <0.05 are statistically signiﬁcant.
Table 4 Intraoperative diastolic arterial blood pressure
(mmHg). Data are presented as mean ± SD.
Time Group D (n= 25) Group P (n= 25)
Preinduction 81.76 ± 7.36 79.36 ± 7.69
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After a pilot study in ten patients, the mean intraoperative
blood loss (SD) was 621 (143) and 782 (338) in the dexmedeto-
midine group and the placebo group, respectively. Therefore,
the sample size was calculated using the program of
Biostatistics version 3.01; twenty-ﬁve per group was needed
to show a difference of intraoperative blood loss of 161 ml
(SD 195 ml) between groups with the power set at 80% and
the a-error level ﬁxed at 0.05.
Data are presented as mean ± standard deviation or med-
ian (range) or numbers as appropriate. Numerical data were
analyzed by using Student’s unpaired t test. Nonparametric
data were analyzed by using Mann–Whitney U-test. A value
of P< 0.05 was considered statistically signiﬁcant.
4. Results
All patients completed the study. Patient’s characteristics and
operative time showed no statistical signiﬁcant difference
between the two studied groups, as given in Table 1.
Intraoperative heart rate was statistically signiﬁcantly lower
in group D than in group P except at 60 min, as given in
Table 2.Table 1 Demographic data and operative time. Data are





Age (year) 39.6 ± 10.07 37.6 ± 10.87
Weight (kg) 81.52 ± 9.23 86.08 ± 9.00
Height (cm) 168.32 ± 9.33 167.36 ± 9.15
Sex (male/female) 19/6 20/5
Duration of operation
(minutes)
116.6 ± 23.52 124.56 ± 14.35
Group D: dexmedetomidine group.
Group P: placebo group.
No statistically signiﬁcant difference between the study groups, P
value >0.05.
Table 2 Intraopeartive heart rate (Bpm). Data are presented
as mean ± SD.
Time Group D (n= 25) Group P (n= 25)
Preinduction 80.44 ± 7.43 80.88 ± 9.75
After induction 71.4 ± 8.86 82.6 ± 10.35*
15 min 70.72 ± 8.27 82.36 ± 9.87*
30 min 70.68 ± 7.73 80.92 ± 10.02*
45 min 71.32 ± 8.29 81.44 ± 10.09*
60 min 76.04 ± 7.51 80.88 ± 9.75
75 min 72.36 ± 4.53 80.68 ± 9.82*
90 min 70.2 ± 3.76 80.04 ± 10.57*
105 min 70.36 ± 3.74 80.88 ± 9.75*
120 min 67.6 ± 5.26 81.36 ± 10.23*
135 min 72.88 ± 8.10 80.44 ± 10.53*
Group D: dexmedetomidine group.
Group P: placebo group.
Bpm= beat per minute.
* P values <0.05 are statistically signiﬁcant.
After induction 74.88 ± 7.49 77.72 ± 7.54
15 min 69.24 ± 6.81 78.12 ± 7.89*
30 min 69.68 ± 5.90 77.29 ± 8.33*
45 min 68.84 ± 6.85 76.83 ± 7.92*
60 min 70.96 ± 5.62 77.45 ± 7.91*
75 min 74.4 ± 8.98 78.60 ± 8.18
90 min 68.16 ± 6.76 78.60 ± 8.18*
105 min 72.72 ± 10.24 79.83 ± 8.37*
120 min 73.88 ± 9.08 79.83 ± 8.37*
135 min 73.96 ± 9.03 77.75 ± 8.44
Group D: dexmedetomidine group.
Group P: placebo group.
* P values <0.05 are statistically signiﬁcant.Intraoperative systolic arterial blood pressure was statisti-
cally signiﬁcantly lower in D group than in P group at 60,
105, 120, and 135 min, as given in Table 3.
Intraoperative diastolic arterial blood pressure was statisti-
cally signiﬁcantly lower in D group than in P group except at
75 and 135 min, as given in Table 4.
The intraoperative blood volume lost was statistically
signiﬁcant higher in group P than group D, number of units
of PRBCs transfused, intraoperative and postoperative
hemoglobin % and hematocrit concentration were statistically
signiﬁcant lower in group P than group D, number of units of
PRBCs transfused was statistically signiﬁcantly higher in
group P than group D, Table 5.
5. Discussion
Dexmedetomidine is a highly selective a 2-adrenoceptor
agonist [9,10], with hemodynamic stability, analgesic and
sympatholytic effects it also maintains adequate organ
perfusion [11]. It attenuates the stress responses during surgery
and maintains intraoperative hemodynamics [12,13].
The main ﬁnding in this study was that dexmedetomidine
infusion in adult patients undergoing open nephrolithotomy
Table 5 Volume of blood loss (ml), units of PRBCs
transfused, laboratory Hb%, Htc. Data are presented as





Volume of blood loss (ml) 636 ± 233.86 804 ± 379.18*
Units of PRBCs
transfused
0 1 (0–1) *
Hb%
Preoperative 12.4 ± 0.90 12.10 ± 0.88
Intraoperative 9.31 ± 0.38 8.90 ± 0.53*
Postoperative 10.10 ± 0.62 9.76 ± 0.55*
Htc
Preoperative 33.93 ± 2.28 32.19 ± 2.69
Intraoperative 28.92±.69 26.93±.91*
Postoperative 29.87 ± 1.3 28.82 ± 1.33*
Group D: dexmedetomidine group.
Group P: placebo group.
* P values <0.05 are statistically signiﬁcant.
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hemodynamic stability, which decreases intraoperative blood
loss and the need for intraoperative blood transfusion. The
heart rate and systolic and diastolic blood pressure were statis-
tically signiﬁcantly lower in dexmedetomidine group compared
to the placebo group without development of bradycardia or
hypotension, no patient had initial hypertension due to slow
administration of dexmedetomidine bolus infusion over
10 min which was proved to decrease the initial hypertension
and reﬂex bradycardia associated with a rapid administration
of dexmedetomidine [10].
In agreement with the results of the present study, a study
by Rao et al. [10] showed that patients who underwent elective
surgeries under general anesthesia (e.g., oral, maxillofacial and
ENT, general, orthopedic, spine, brain, thyroid, laparoscopy)
and given a loading dose of dexmedetomidine 1 lg/kg and
then continuous infusion of 0.5 lg/kg/h had a stable intraoper-
ative hemodynamics, and a study by Kang et al. [14] in patients
undergoing breast surgery concluded that dexmedetomidine
(1 lg/kg) given before induction of anesthesia followed by
infusion of (0.6 lg/kg/h) resulted in hemodynamic stability.
A study by Yacout et al. [15] showed that intravenous
dexmedetomidine infusion in patients scheduled for elective
major abdominal surgery under general anesthesia was associ-
ated with signiﬁcantly lower heart rate and mean arterial blood
pressure compared to the placebo group.
In line with the current study, Tanskanen et al. [16] showed
that intraoperative infusion of dexmedetomidine at a rate of
0.4 lg/kg/h maintains heart rate and blood pressure compared
to the placebo group in patients undergoing supratentorial
brain tumor surgery and provided perioperative hemodynamic
stability.
In this study no patient had bradycardia in dexmedeto-
midine group, which was in agreement with the study by
Gurbet et al. [17] who reported that bradycardia did not
develop in patients scheduled for total abdominal hysterec-
tomy and received a loading dose of dexmedetomidine 1 lg/kg
IV during induction of anesthesia, followed by a continuous
infusion at a rate of 0.5 lg/kg/h.
Jagadish and his coworkers [18] showed that dexmedeto-
midine infusion 1 lg/kg before induction of anesthesia andthen continuous infusion at a dose of 0.2–0.7 lg/kg/h intraop-
erative caused decrease in arterial blood pressure and heart
rate with maintenance of hemodynamic stability in patients
scheduled for elective surgeries (e.g., thyroidectomy and
abdominal surgeries) under general anesthesia.
In a study by Varshali et al. [19] two patients receiving
dexmedetomidine had bradycardia without decrease in arterial
blood pressure and responded to IV atropine, and they
concluded that dexmedetomidine maintains hemodynamic
stability in patients undergoing major surgical procedure.
Dexmedetomidine causes peripheral vasoconstriction,
which resulted in minimal bleeding with skin incision and
intraoperative [3].
Previous studies reported that dexmedetomidine decreased
bleeding during septoplasty and tympanoplasty with mainte-
nance of intraoperative hemodynamic stability [11,20], in spine
surgery, dexmedetomidine infusion reduces intraoperative
blood loss and blood transfusion rate [9], and when it is used
as adjuvant to general anesthesia in patients undergoing scol-
iosis correction surgery, it effectively decreased the amount
of blood loss and was associated with stable hemodynamics
[21].
A study by El-Gohary and Arafa [22] in patients underwent
scoliosis correction surgery and received a bolus of dexmedeto-
midine IV 1 lg/kg over 10 min before induction of anesthesia
and continued as 0.2–0.5 lg/kg/h infusion reduced the blood
loss and the need of blood transfusion.6. Conclusion
Dexmedetomidine infusion in patients undergoing open
nephrolithotomy under general anesthesia was associated with
intraoperative hemodynamic stability, which decreases intra-
operative blood loss and the need for intraoperative blood
transfusion.Conﬂict of interest
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